"Acetates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure.
Descriptor ID |
D000085
|
MeSH Number(s) |
D02.241.081.018 D10.251.400.045
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Acetates".
Below are MeSH descriptors whose meaning is more specific than "Acetates".
This graph shows the total number of publications written about "Acetates" by people in this website by year, and whether "Acetates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 1 | 1 |
2010 | 2 | 0 | 2 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acetates" by people in Profiles.
-
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function. J Immunol Res. 2014; 2014:608930.
-
Montelukast: more than a cysteinyl leukotriene receptor antagonist? ScientificWorldJournal. 2010 Dec 14; 10:2403-13.
-
Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. Eur Respir J. 2010 Dec; 36(6):1417-24.
-
Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants. Inflamm Res. 2009 May; 58(5):263-8.
-
Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol. 2009 Jan; 156(1):105-15.
-
Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia. Atherosclerosis. 2003 Dec; 171(2):273-9.